Subcutaneous administration of immunoglobulins - What are the advantages?

Immunoglobulin (IgG) therapy has hitherto mainly been given as intramuscular injections of intravenous infusions, However, due to disadvantages using these methods, we have developed a method for rapid subcutaneous infusion of IgG which is well tolerated (no virus transmission and no severe adverse reactions). improves the health-related quality of life. is highly appreciated by patients and leads to reduced costs for the healthcare sector and the patients. Altogether, more than 60000 subcutaneous IgG infusions have now been given to patients with primary and secondary antibody deficiencies. Our experience suggests that this form of therapy constitutes the current treatment of choice both for the clinician and the patient.